Reference source : Ministry of Environment
Taiwan Taiwan Ministry of Environment MoENV Substances of concern Classification and Labelling Amendment
On 20 July , 2026 Taiwan's Ministry of Environment (MOE) has released a draft amendment proposing to add six additional substances to the Concerned Chemical Substances list under the Toxic and Concerned Chemical Substances Control Act. The proposal aims to strengthen chemical risk management, improve supply chain traceability, and reduce potential risks to human health and the environment. The amendment also introduces new concentration thresholds, labelling obligations, approval requirements, and transition periods for affected businesses.
Summary
The draft amendment proposes to regulate six additional chemicals by introducing requirements for manufacturing, importing, selling, using, and storing these substances. Depending on the substance and concentration, companies may be required to obtain prior approval, submit monthly operational reports, maintain operational records, prepare Safety Data Sheets (SDSs), and update product labels and packaging.
Existing operators will be provided with a transition period to comply with the new requirements before full implementation.
Six Chemicals Proposed for Regulation
The proposed amendment would add the following substances:
Why Are These Chemicals Being Added?
According to the Ministry of Environment:
Proposed Regulatory Requirements
The draft introduces different regulatory requirements based on each substance.
Toluidine Red and Para Red
Key proposed requirements include:
Bisphenol B and Bisphenol F
Key proposed requirements include:
MMMP
Key proposed requirements include:
Gamma-Butyrolactone (GBL)
The proposal introduces a two-tier regulatory approach:
Compliance Timeline
The draft amendment provides an implementation schedule for existing operators:
Additional Restrictions
The Ministry also announced that once the six substances are officially designated as Concerned Chemical Substances:
What Companies Should Do
Companies manufacturing, importing, distributing, or using any of the six proposed substances in Taiwan should begin reviewing their compliance obligations. Businesses are encouraged to assess product portfolios, concentration levels, labeling, Safety Data Sheets, operational record systems, and approval requirements in preparation for the final regulation.